Abstract
Spaceflight presents many challenges and opportunities for understanding human physiology and for administering healthcare in a harsh, remote and resource-limited environment. Technologies and countermeasures developed for space must be portable, minimize invasiveness, and be easy to use and maintain. Medical devices must also be robust and preferably require low power and consumables. Solutions meeting these standards for spaceflight have potential commercial advantages over similar technologies developed only for Earth markets. Many technologies for space have Earth-based spin-offs. In medicine, recent advances from space enhancing terrestrial healthcare delivery include, but are not limited to, (1) new training methods, and advanced diagnostic and therapeutic applications for ultrasound, (2) near-infrared spectroscopy for portable brain imaging, and (3) non-invasive assessment of intracranial pressure. With the assistance of the National Space Biomedical Research Institute (NSBRI), funding for biomedical innovation and applications for space includes a program aimed at small companies, with commercialization support competitively awarded to transition technologies from bench to market.
Keywords: Astronaut, biomedical, commercialization, exploration, health, healthcare, innovation, intracranial pressure, medical, microgravity, near-infrared spectrocopy, non-invasive, public private partnership, space, spaceflight, technology, ultrasound.
Current Biotechnology
Title:Biomedical Advances for Spaceflight Improve Healthcare on Earth
Volume: 2 Issue: 3
Author(s): Dorit B. Donoviel and Jeffrey P. Sutton
Affiliation:
Keywords: Astronaut, biomedical, commercialization, exploration, health, healthcare, innovation, intracranial pressure, medical, microgravity, near-infrared spectrocopy, non-invasive, public private partnership, space, spaceflight, technology, ultrasound.
Abstract: Spaceflight presents many challenges and opportunities for understanding human physiology and for administering healthcare in a harsh, remote and resource-limited environment. Technologies and countermeasures developed for space must be portable, minimize invasiveness, and be easy to use and maintain. Medical devices must also be robust and preferably require low power and consumables. Solutions meeting these standards for spaceflight have potential commercial advantages over similar technologies developed only for Earth markets. Many technologies for space have Earth-based spin-offs. In medicine, recent advances from space enhancing terrestrial healthcare delivery include, but are not limited to, (1) new training methods, and advanced diagnostic and therapeutic applications for ultrasound, (2) near-infrared spectroscopy for portable brain imaging, and (3) non-invasive assessment of intracranial pressure. With the assistance of the National Space Biomedical Research Institute (NSBRI), funding for biomedical innovation and applications for space includes a program aimed at small companies, with commercialization support competitively awarded to transition technologies from bench to market.
Export Options
About this article
Cite this article as:
Donoviel B. Dorit and Sutton P. Jeffrey, Biomedical Advances for Spaceflight Improve Healthcare on Earth, Current Biotechnology 2013; 2 (3) . https://dx.doi.org/10.2174/22115501113029990018
DOI https://dx.doi.org/10.2174/22115501113029990018 |
Print ISSN 2211-5501 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-551X |
Call for Papers in Thematic Issues
Age Reversal using transient epigenetc reprogramming with the OSK Yamanaka Factors
Aging is a complex biological process characterized by a gradual deterioration of physiological functions and an increased vulnerability to disease. Recent advancements in the field of regenerative medicine have shown promising avenues for combating aging. Among these, partial epigenetic reprogramming, specifically utilizing the Yamanaka factors, has been shown to reverse ...read more
Bioinformatic Analysis of Regulated Cell Death in Chronic and Acute Inflammatory Diseases
In the intricate realm of inflammatory diseases, delving into the complexities surrounding regulated cell death emerges as an indispensable and forefront area of exploration. Understanding the intricacies of how cells are regulated to undergo death in inflammatory conditions not only represents a pivotal frontier in biomedical research but also holds ...read more
Feeding a vegan World
The Eat-Lancet Planetary diet recommends at least 2/3 plant and microbial sources in the food protein portion. Such diet is recommended against obesity, cancer and to limit global warming, and might get more and more incentives in the next years. We thus need massive amounts of Plant-based food, and the ...read more
Leveraging AI for personalized pediatric neurodevelopmental support
Personalized medicine in pediatrics is a moving target dedicated to finding the right treatment, at the right time, for each individual child in each stage of development. Child development is a highly personal process, unique to each individual, something which is even more apparent in the development of children with ...read more
Related Journals
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Differentiation of High-grade Gliomas from Brain Metastases Using Tissue Similarity Maps (TSMs) Based Relative Cerebral Blood Volume Values
Current Medical Imaging The Physiology and Pathophysiology of a Novel Angiotensin Receptor-binding Protein ATRAP/Agtrap
Current Pharmaceutical Design Chemistry, Biological Properties and SAR Analysis of Quinoxalinones
Mini-Reviews in Medicinal Chemistry Medications Acting on the GABA System in the Treatment of Alcoholic Patients
Current Pharmaceutical Design Manipulation of the Immune System for Cancer Defeat: A Focus on the T Cell Inhibitory Checkpoint Molecules
Current Medicinal Chemistry Mechanisms and Inhibitors of Apoptosis in Cardiovascular Diseases
Current Pharmaceutical Design Chemo-botanical and Neurological Accounts of Some Ayurvedic Plants Useful in Mental Health
The Natural Products Journal Design of Lipophilic Prodrugs to Improve Drug Delivery and Efficacy
Current Drug Targets Inflammation in Ischemic Stroke Subtypes
Current Pharmaceutical Design Fruits for Seizures? A Systematic Review on the Potential Anti-Convulsant Effects of Fruits and their Phytochemicals
Current Neuropharmacology Human Fetal Pigmented Ciliary Epithelium Stem Cells have Regenerative Capacity in the Murine Retinal Degeneration Model of Laser Injury
Current Neurovascular Research Edible Nuts for Memory
Current Pharmaceutical Design Mechanistic Modeling of Soluble Aβ Dynamics and Target Engagement in the Brain by Anti-Aβ mAbs in Alzheimer’s Disease
Current Alzheimer Research Iptakalim Hydrochloride and Neuronal Protection
Current Neuropharmacology Recent Advances on the Possible Neuroprotective Activities of Epstein- Barr Virus Oncogene BARF1 Protein in Chronic Inflammatory Disorders of Central Nervous System
Current Neuropharmacology Nanogel-based Transdermal Drug Delivery System: A Therapeutic Strategy with Under Discussed Potential
Current Topics in Medicinal Chemistry Olanzapine Does not Aggrevate Ischemic Neuronal Injury by Focal Cerebral Ischemia: A Dose Related Restriction of the Neuroprotective Effect?
Medicinal Chemistry Chemotherapeutic Options for Colorectal Cancer Patients with Cardiovascular Diseases.
Reviews on Recent Clinical Trials Advances in Understanding the Notch Signaling Pathway in the Cochlea
Current Pharmaceutical Design Cytokines in Neuroinflammation and Alzheimers Disease
Current Drug Targets